Roche's gantenerumab 'shows sign of preventing Alzheimer's dementia'

A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to remove amyloid plaques from the brain years before symptoms arise may delay the onset of Alzheimer's dementia – although some specialists have urged caution in interpreting the data.